Daiwa Securities Group
RMD icon

Daiwa Securities Group’s ResMed RMD Stock Holding History

Daiwa Securities Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.97M Buy
35,522
+2,746
+8% +$684K 0.02% 366
2025
Q4 		$7.89M Buy
32,776
+3,046
+10% +$779K 0.03% 358
2025
Q3 		$8.14M Buy
29,730
+636
+2% +$174K 0.03% 344
2025
Q2 		$7.51M Buy
29,094
+1,534
+6% +$366K 0.03% 341
2025
Q1 		$6.17M Buy
27,560
+2,441
+10% +$570K 0.03% 356
2024
Q4 		$5.74M Buy
25,119
+1,320
+6% +$318K 0.03% 361
2024
Q3 		$5.81M Buy
23,799
+2,389
+11% +$534K 0.03% 344
2024
Q2 		$4.1M Buy
21,410
+4,066
+23% +$825K 0.02% 384
2024
Q1 		$3.44M Buy
17,344
+3,890
+29% +$713K 0.02% 411
2023
Q4 		$2.31M Buy
13,454
+993
+8% +$153K 0.01% 483
2023
Q3 		$1.84M Buy
12,461
+682
+6% +$123K 0.01% 518
2023
Q2 		$2.57M Buy
11,779
+412
+4% +$91.8K 0.02% 429
2023
Q1 		$2.49M Buy
11,367
+696
+7% +$151K 0.02% 434
2022
Q4 		$2.22M Buy
10,671
+779
+8% +$171K 0.02% 448
2022
Q3 		$2.16M Buy
9,892
+586
+6% +$133K 0.02% 436
2022
Q2 		$1.95M Buy
9,306
+320
+4% +$68.1K 0.01% 461
2022
Q1 		$2.18M Buy
8,986
+492
+6% +$119K 0.01% 469
2021
Q4 		$2.21M Buy
8,494
+364
+4% +$94.5K 0.01% 484
2021
Q3 		$2.14M Buy
8,130
+338
+4% +$92.4K 0.01% 460
2021
Q2 		$1.92M Buy
7,792
+126
+2% +$26.5K 0.01% 458
2021
Q1 		$1.49M Sell
7,666
-256
-3% -$51.3K 0.01% 506
2020
Q4 		$1.68M Buy
7,922
+668
+9% +$133K 0.01% 435
2020
Q3 		$1.24M Buy
7,254
+406
+6% +$75K 0.01% 454
2020
Q2 		$1.01M Hold
6,848
– – 0.02% 356
2020
Q1 		$1.01M Buy
6,848
+900
+15% +$143K 0.01% 462
2019
Q4 		$922K Sell
5,948
-270
-4% -$38.9K 0.01% 550
2019
Q3 		$840K Buy
6,218
+421
+7% +$55.2K 0.01% 555
2019
Q2 		$1.21M Buy
5,797
+230
+4% +$25.5K 0.01% 448
2019
Q1 		$1.36M Sell
5,567
-823
-13% -$84.9K 0.01% 420
2018
Q4 		$728K Buy
6,390
+823
+15% +$88.2K 0.01% 519
2018
Q3 		$1.12M Buy
5,567
+630
+13% +$69K 0.01% 484
2018
Q2 		$511K Hold
4,937
– – ﹤0.01% 631
2018
Q1 		$486K Buy
4,937
+657
+15% +$62.1K ﹤0.01% 628
2017
Q4 		$362K Buy
4,280
+53
+1% +$4.38K ﹤0.01% 710
2017
Q3 		$325K Buy
4,227
+27
+0.6% +$2.06K ﹤0.01% 690
2017
Q2 		$327K Buy
4,200
+350
+9% +$25K ﹤0.01% 657
2017
Q1 		$277K Hold
3,850
– – ﹤0.01% 693
2016
Q4 		$239K Buy
3,850
+400
+12% +$24.5K ﹤0.01% 720
2016
Q3 		$224K Buy
3,450
+450
+15% +$30K ﹤0.01% 661
2016
Q2 		$190K Sell
3,000
-11,200
-79% -$660K ﹤0.01% 679
2016
Q1 		$821K Buy
14,200
+4,300
+43% +$243K 0.01% 414
2015
Q4 		$532K Sell
9,900
-700
-7% -$39.5K ﹤0.01% 468
2015
Q3 		$540K Sell
10,600
-1,300
-11% -$70K ﹤0.01% 472
2015
Q2 		$671K Buy
11,900
+3,400
+40% +$215K ﹤0.01% 466
2015
Q1 		$610K Buy
8,500
+5,300
+166% +$344K ﹤0.01% 422
2014
Q4 		$179K Hold
3,200
– – ﹤0.01% 671
2014
Q3 		$158K Sell
3,200
-400
-11% -$20.4K ﹤0.01% 715
2014
Q2 		$182K Hold
3,600
– – ﹤0.01% 685
2014
Q1 		$161K Hold
3,600
– – ﹤0.01% 710
2013
Q4 		$169K Hold
3,600
– – ﹤0.01% 708
2013
Q3 		$190K Hold
3,600
– – ﹤0.01% 659
2013
Q2 		$162K Buy
+3,600
New +$171K ﹤0.01% 712

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Daiwa Securities Group's RMD Position: Q1 2026 in Review

Daiwa Securities Group increased its ResMed (RMD) stake by 8.4% in Q1 2026, buying an estimated $684K and bringing the position to 35,522 shares worth $7.97M. The position accounts for 0.02% of the portfolio, ranked #366.

Daiwa Securities Group first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.14M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Daiwa Securities Group held 35,522 shares of ResMed worth $7.97M as of Q1 2026.
  • Daiwa Securities Group bought 2,746 ResMed shares in Q1 2026, an estimated $684K.
  • ResMed made up 0.02% of Daiwa Securities Group's portfolio in Q1 2026, its #366 holding.
  • Daiwa Securities Group first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • Daiwa Securities Group's ResMed position peaked at $8.14M in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.